Dynamic Analysis of the Biochemical Changes in Rats with Polycystic Ovary Syndrome (PCOS) Using Urinary 1H NMR-Based Metabonomics

Wei Huang,Shanxia Li,Naxin Luo,Kena Lu,Sheng Ban,Hanmei Lin

DOI: https://doi.org/10.1055/a-1073-2346

2020-01-01

Hormone and Metabolic Research

Abstract:Abstract Polycystic ovarian syndrome (PCOS) is the most common endocrine disease that causes reproductive abnormalities in fertile women. It is closely related to the persistent anovulatory, insulin resistance, and high androgen. However, the molecular mechanisms underlying the pathological development of PCOS are still unclear. In this study, we aimed to explore the distinctive metabolic patterns in insulin combined with human chorionic gonadotrophin induced PCOS. The dynamic changes of endogenous metabolites in the development of PCOS were studied using untargeted metabolomic approaches based on nuclear magnetic resonance. The results showed that the degree of PCOS disorder metabolites at different periods was not exactly the same. Twelve significantly differential endogenous metabolites from different time points were selected as potential biomarkers relate to pathological process of PCOS. Among them, six metabolites showed a good diagnostic accuracy with PCOS model. The arginine and proline metabolic pathway was considered as one of the most crucial pathways that affects occurrence and development of PCOS. In addition, IRS-1, Akt, PI3K, IκB, and NF-κB (p65) were significantly changed in the ovary tissue of PCOS rats, which revealed that the IRS-1-PI3K/Akt and NF-κB signal pathway may be involved in the development of PCOS. This study demonstrated that metabolomic analysis is a powerful tool for providing novel insight into understanding the pathogenesis of PCOS and provide a basic reference for the diagnosis of PCOS at the onset stage.

endocrinology & metabolism

What problem does this paper attempt to address?

The problem that this paper attempts to solve is that the pathogenesis of polycystic ovary syndrome (PCOS) is not yet fully understood, especially in terms of metabolic changes at different stages. Through dynamic metabolomics analysis, the authors aim to study the metabolic changes during the development of PCOS from a holistic and dynamic perspective, in order to more comprehensively reveal the pathogenesis of PCOS. Specifically, the study used a non - targeted metabolomics method based on nuclear magnetic resonance (NMR) to analyze the changes in urinary metabolites in PCOS rats at different time points and explored the relationship between these metabolic changes and the pathological process of PCOS. In addition, the study also examined the protein expression related to the metabolomics findings to further clarify the molecular biological mechanism of PCOS. The main objectives of the paper include: 1. **Explore the metabolic characteristics of PCOS**: By analyzing the metabolite changes in PCOS rats at different time points, identify potential biomarkers related to the pathological process of PCOS. 2. **Reveal the changes in metabolic pathways**: Determine the metabolic pathways that change significantly during the development of PCOS, especially the arginine and proline metabolic pathways. 3. **Explore the changes in signal pathways**: Through Western blot analysis, study the expression changes of IRS - 1 - PI3K/Akt and NF - κB signal pathways in the ovarian tissue of PCOS rats to understand the role of these signal pathways in the pathogenesis of PCOS. Through these studies, the authors hope to provide new insights and references for the early diagnosis and treatment of PCOS.

Dynamic Analysis of the Biochemical Changes in Rats with Polycystic Ovary Syndrome (PCOS) Using Urinary 1H NMR-Based Metabonomics

Untargeted Metabolomics Analysis of Serum and Follicular Fluid Samples from Women with Polycystic Ovary Syndrome.

Metabonomics Reveals Plasma Metabolic Changes and Inflammatory Marker in Polycystic Ovary Syndrome Patients

Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis

Blood Volatile Organic Compounds as potential biomarkers for poly cystic ovarian syndrome (PCOS): An animal study in the PCOS rat model

Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry

Alteration of Branched-Chain and Aromatic Amino Acid Profile as a Novel Approach in Studying Polycystic Ovary Syndrome Pathogenesis

Inferring Causal Relationships Between Metabolites and Polycystic Ovary Syndrome Using Summary Statistics from Genome‑Wide Association Studies

Searching for the primary metabolic alterations of polycystic ovary syndrome by application of the untargeted metabolomics approach

The vaginal metabolomics profile with features of polycystic ovary syndrome: a pilot investigation in China

Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome

Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry

Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome

How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics

Serum metabolomic profiling reveals potential biomarkers in assessing the management of women with polycystic ovary syndrome: a randomized controlled trial

Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites

Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome

Characterization of Reproductive, Metabolic, and Endocrine Features of Polycystic Ovary Syndrome in Female Hyperandrogenic Mouse Models

A Molecular and Cellular Review of the Literature

Polycystic ovarian syndrome is accompanied by repression of gene signatures associated with biosynthesis and metabolism of steroids, cholesterol and lipids

Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model